iiinova — where your digital self keeps evolving

Tom Marjot @tom-marjot.bsky.social · 11/08/2025

Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September 📢Attendance is FREE and registration is EASY. There are still a few spaces left. 🔗(tinyurl.com/4j8esadr) Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates

Programme for BASL MASLD SIG meeting 5th September 2025

Venue details for BASL MASLD SIG meeting 5th September 2025

020 0

Tom Marjot @tom-marjot.bsky.social · 25/05/2025

📢Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social 💪We've covered everything you need to know about #Muscle & #MASLD - Insulin resistance - Sarcopenia - Myosteatosis - Impact of weight loss drugs - Benefits of exercise 🔗 shorturl.at/aFO1Q #LiverSky

Graphic showing assessment methods for various domains of muscle quality and function in patients with MASLD including insulin resistance, myosteatosis, sarcopenia, and frailty.

1112 0

Reposted by Tom Marjot

Rui Castro @ruicastrohd.bsky.social · 15/04/2025

BS @easlnews.bsky.social Congress Wed 7🗓️Whole-day seminar plus a wet lab on spatial biology (NEW THIS YEAR‼️) Thu 8🗓️State of the Art by Lars Zender Fri 9🗓️MTE sessions on MASLD & MetALD Sat 10🗓️Microbiome session co-chaired by our own @debbieshawcross.bsky.social & more!🔗https://tinyurl.com/4ky9r3x9

194 0

Reposted by Tom Marjot

Eric Topol @erictopol.bsky.social · 06/03/2025

In these unprecedented dark times for American life science and medical research (no less well beyond biomedicine), my coping mechanism is to laser focus on the unremitting and remarkable daily advances, and the fervent hope these will not be slowed or interrupted.

281280152 0

Tom Marjot @tom-marjot.bsky.social · 17/03/2025

Original paper in @nature.com : 🔗https://shorturl.at/jcWYE 👏 @gjpattij.bsky.social BBJ article in Journal of Hepatology: 🔗https://shorturl.at/4E2qT @jhepatology.bsky.social @easlnews.bsky.social

030 0

Tom Marjot @tom-marjot.bsky.social · 17/03/2025

Breakthroughs Beyond the Journal @jhepatology.bsky.social 🚨The liver is central to fructose-associated cancer ▶️Tumors cannot use fructose directly ▶️Liver converts to specific lipids (LPC) ▶️LPCs integrate into new cancer membranes Can this explain link between MASLD & extra-hepatic cancer?

Highlights from latest article in Breakthroughs Beyond the Journal in Journal of Hepatology. It showcases work published in Nature.

161 0

Reposted by Tom Marjot

Elliot Tapper @ebtapper.bsky.social · 25/01/2025

There has been a recent influx to #gisky and #liversky To sustain this, you need to be active. If you were a lurker, no we need your pearls, papers, and pets. Post. Use the hashtags. Build.

14715 0

Reposted by Tom Marjot

Rui Castro @ruicastrohd.bsky.social · 24/01/2025

Young Investigator Poster Tour @easlnews.bsky.social #SLDSummit Huge attendance and interest! 👏🏼 @tom-marjot.bsky.social @madsisraelsen.bsky.social

042 0

Reposted by Tom Marjot

EASL @easlnews.bsky.social · 15/01/2025

2025 is the perfect year to take your career to the next level🚀 There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force. Apply by 20 January: easl.eu/leadership25 #LiverSky

0125 0

Reposted by Tom Marjot

Adlung Lab @adlunglab.com · 05/01/2025

Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. 🧪 www.nature.com/articles/s41...

nature.com

Alcohol-free and low-strength drinks: friend or foe? - Nature Reviews Gastroenterology & Hepatology

Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and benefits of these products is nuanced and evolving, part...

263 0

Reposted by Tom Marjot

Ashwin Dhanda @adhanda.bsky.social · 03/01/2025

Do read my comment piece with @tom-marjot.bsky.social on NoLo alcohol 👇🏾

164 0

Tom Marjot @tom-marjot.bsky.social · 02/01/2025

1: In 2025, look out for a new section in Journal of Hepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research. #LiverSky 2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two conditions works BOTH ways👇

New evidence of cross-disease communication between heart and liver

1121 0

Reposted by Tom Marjot

NEJM.org @nejm.org · 06/12/2024

Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:

32858187 0

Reposted by Tom Marjot

Andrew Moon @andrewmmoon.bsky.social · 27/11/2024

Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it? A systematic review in @amcollegegastro.bsky.social #AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years #LiverSky Link: journals.lww.com/ajg/abstract...

0199 0

Tom Marjot @tom-marjot.bsky.social · 26/11/2024

#LiverSky Useful tip... There's no 'bookmark' function in Bluesky currently. But there is a nice work-around: 1) Reply to the post of interest with a📌emoji 2) Click on this link bsky.app/profile/did:... 3) Click 'Pin to Home' This will collate📌posts in a tab on your home screen + ⬆️ engagement.

9208 0

Reposted by Tom Marjot

Atoosa Rabiee @atoosarabiee.bsky.social · 20/11/2024

1/3 What happens when science and every day clinical practice comes together? A 🧵 You get a packed room with not even a place to stand 👇🏼 Why? I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings. #TLM24

1123 0

Reposted by Tom Marjot

Elisabeth Bik @elisabethbik.bsky.social · 20/11/2024

This artwork was published in the Journal of Immunology, published by @immunologyaai.bsky.social - which appears not to give a fork. pubpeer.com/publications... The Chinese government also did not see any problem. www.science.org/content/arti... #ThisImageIsFine

A figure from a scientific paper showing a single Flow Cytometry (FACS) panel. It looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

A figure from a scientific paper showing four Flow Cytometry (FACS) panels. Each looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.

3305 0

Reposted by Tom Marjot

Elliot Tapper @ebtapper.bsky.social · 15/11/2024

We are on our second starter pack for GI / Hepatology Part 1: go.bsky.app/8Pho2tp Part 2: go.bsky.app/VGyLKjR #medsky #GIsky #LiverSky

239932 0